Form 4: AnaptysBio Director Ware J. Anthony Reports Stock Transactions
SEC Form 4 Filing
Director Ware J. Anthony reports the disposition of 3,900 shares of AnaptysBio common stock and the vesting of 3,900 restricted stock units on June 15, 2024.
Summary
- On June 15, 2024, AnaptysBio Director Ware J. Anthony reported transactions involving the company's stock.
- The transactions included the disposition of 3,900 shares of common stock.
- Additionally, 3,900 restricted stock units (RSUs) vested on the same date.
- The RSUs convert into common stock upon settlement, with 100% vesting occurring on the date of the Issuer's 2024 annual meeting of shareholders, contingent on continued service.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/15/2024 | Date of the reported transactions: disposition of common stock and vesting of restricted stock units. |
| 06/18/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.